BLACKBERRY LTD (BB.CA)

CA09228F1036 - Common Stock

5.64  +0.21 (+3.87%)

Fundamental Rating

3

Overall BB gets a fundamental rating of 3 out of 10. We evaluated BB against 69 industry peers in the Software industry. BB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BB is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

BB had positive earnings in the past year.
In the past year BB has reported a negative cash flow from operations.
BB had negative earnings in 4 of the past 5 years.
In multiple years BB reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -10.62%, BB is in line with its industry, outperforming 44.12% of the companies in the same industry.
The Return On Equity of BB (-18.85%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.62%
ROE -18.85%
ROIC N/A
ROA(3y)-17.52%
ROA(5y)-19.13%
ROE(3y)-33.88%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BB has a better Gross Margin (70.02%) than 73.53% of its industry peers.
In the last couple of years the Gross Margin of BB has declined.
BB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.4%
GM growth 5Y-4.67%

3

2. Health

2.1 Basic Checks

BB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BB has more shares outstanding
BB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BB has been reduced compared to a year ago.

2.2 Solvency

BB has an Altman-Z score of 0.58. This is a bad value and indicates that BB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.58, BB is in line with its industry, outperforming 48.53% of the companies in the same industry.
BB has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BB (0.27) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACCN/A
WACC10.21%

2.3 Liquidity

BB has a Current Ratio of 1.44. This is a normal value and indicates that BB is financially healthy and should not expect problems in meeting its short term obligations.
BB has a Current ratio of 1.44. This is comparable to the rest of the industry: BB outperforms 55.88% of its industry peers.
A Quick Ratio of 1.44 indicates that BB should not have too much problems paying its short term obligations.
The Quick ratio of BB (1.44) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.44

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.00% over the past year.
The earnings per share for BB have been decreasing by -23.57% on average. This is quite bad
BB shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.03%.
Measured over the past years, BB shows a decrease in Revenue. The Revenue has been decreasing by -1.15% on average per year.
EPS 1Y (TTM)100%
EPS 3Y-30.66%
EPS 5Y-23.57%
EPS Q2Q%100%
Revenue 1Y (TTM)30.03%
Revenue growth 3Y-1.52%
Revenue growth 5Y-1.15%
Sales Q2Q%-18.29%

3.2 Future

The Earnings Per Share is expected to grow by 30.44% on average over the next years. This is a very strong growth
BB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.11% yearly.
EPS Next Y-136.48%
EPS Next 2Y-1.73%
EPS Next 3Y22.35%
EPS Next 5Y30.44%
Revenue Next Year-27.31%
Revenue Next 2Y-11.54%
Revenue Next 3Y14.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 188.00, BB can be considered very expensive at the moment.
66.18% of the companies in the same industry are more expensive than BB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.30, BB is valued quite expensively.
A Price/Forward Earnings ratio of 67.51 indicates a quite expensive valuation of BB.
Based on the Price/Forward Earnings ratio, BB is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
BB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 188
Fwd PE 67.51

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BB.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 132.87

4.3 Compensation for Growth

BB's earnings are expected to grow with 22.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.73%
EPS Next 3Y22.35%

0

5. Dividend

5.1 Amount

No dividends for BB!.
Industry RankSector Rank
Dividend Yield N/A

BLACKBERRY LTD

TSX:BB (12/27/2024, 7:00:00 PM)

5.64

+0.21 (+3.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-19 2024-12-19/amc
Earnings (Next)N/A N/A
Inst Owners48.47%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap3.33B
Analysts76
Price Target3.57 (-36.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.73%
Min EPS beat(2)31.47%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)114.72%
Min EPS beat(4)31.47%
Max EPS beat(4)191.02%
EPS beat(8)8
Avg EPS beat(8)99.22%
EPS beat(12)12
Avg EPS beat(12)87.97%
EPS beat(16)15
Avg EPS beat(16)84.27%
Revenue beat(2)1
Avg Revenue beat(2)14.77%
Min Revenue beat(2)-0.45%
Max Revenue beat(2)29.99%
Revenue beat(4)2
Avg Revenue beat(4)8.99%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)29.99%
Revenue beat(8)3
Avg Revenue beat(8)19.16%
Revenue beat(12)5
Avg Revenue beat(12)12.46%
Revenue beat(16)6
Avg Revenue beat(16)8.23%
PT rev (1m)0%
PT rev (3m)0.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-49.92%
EPS NY rev (1m)0%
EPS NY rev (3m)48.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE 188
Fwd PE 67.51
P/S 3.63
P/FCF N/A
P/OCF N/A
P/B 3.16
P/tB 70.02
EV/EBITDA 132.87
EPS(TTM)0.03
EY0.53%
EPS(NY)0.08
Fwd EY1.48%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS1.55
BVpS1.79
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.62%
ROE -18.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.02%
FCFM N/A
ROA(3y)-17.52%
ROA(5y)-19.13%
ROE(3y)-33.88%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.4%
GM growth 5Y-4.67%
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA 11.47
Cap/Depr 28.3%
Cap/Sales 2.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.44
Altman-Z 0.58
F-Score4
WACC10.21%
ROIC/WACCN/A
Cap/Depr(3y)32.27%
Cap/Depr(5y)27.96%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3Y-30.66%
EPS 5Y-23.57%
EPS Q2Q%100%
EPS Next Y-136.48%
EPS Next 2Y-1.73%
EPS Next 3Y22.35%
EPS Next 5Y30.44%
Revenue 1Y (TTM)30.03%
Revenue growth 3Y-1.52%
Revenue growth 5Y-1.15%
Sales Q2Q%-18.29%
Revenue Next Year-27.31%
Revenue Next 2Y-11.54%
Revenue Next 3Y14.11%
Revenue Next 5YN/A
EBIT growth 1Y46.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.86%
EBIT Next 3Y82.04%
EBIT Next 5Y57.15%
FCF growth 1Y23.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.63%
OCF growth 3YN/A
OCF growth 5YN/A